-
Put syphilis detection on your radar screen: Overall rates of primary and secondary syphilis have increased slightly for the first time in more than a decade, according to a new report from the Atlanta-based Centers for Disease Control and Prevention (CDC).1
-
Get set to add more generic oral contraceptives (OCs) to your list of available birth control options as Corona, CA-based Watson Pharmaceuticals is rolling out its brand equivalents of Ortho-Cyclen and Ortho-Novum 7/7/7, two popular pills originally developed by Raritan, NJ-based Ortho-McNeil Pharmaceutical.
-
While U.S. abortion rates are dropping, particularly among teens, the decline is not equally shared among all women. Rates have increased among those who are economically disadvantaged, according to just-published research from the New York City-based Alan Guttmacher Institute (AGI).
-
Will your facility soon be implementing the OraQuick Rapid HIV-1 Antibody Test? If so, there are several resources to help you get up to speed in offering this new service.
-
-
STD Quarterly: Register now for HIV prevention conference
-
You have just finished counseling a young woman who is frightened and confused after hearing she has contracted genital herpes. While you are able to offer her daily suppressive therapy to help reduce the frequency of outbreaks, you discuss the fact that there is no cure for this sexually transmitted disease (STD).
-
Editors note: This article discusses a use of quinacrine that has not been approved by the Food and Drug Administration.
-
Puzzled about protocols for dispensing emergency contraception (EC) to male partners? Wondering about the impact of depot medroxy-progesterone acetate (DMPA, Depo-Provera, Pharmacia Corp, Peapack, NJ) on lipid levels?
-
When women enter your family planning clinic, you have a wide array of contraceptive options to offer them. But when men ask about prevention methods, you have three choices: hand them condoms, advise abstinence, or counsel on vasectomy.